Vorsitz: S. D. Anker (Berlin), U. C. Hoppe (Salzburg, AT)
(V952) | Neurohumoral activation as a predictor of changes of physical function after 1-year follow-up in patients with and without diastolic dysfunction and diastolic heart failure |
A. Duvinage, C. Disque, R. Stahrenberg, H.-D. Düngen, G. Hasenfuß, B. Pieske, R. Wachter, C. Herrmann-Lingen, F. Edelmann (Göttingen, Berlin; Graz, AT) | |
(V953) | The ageing process of the heart: Reduced systolic contractility in individuals with mild diastolic dysfunction and preserved ejection fraction The MONICA/KORA Study |
J. Stritzke, C. Moeller, A. Luchner, A. Döring, H. W. Hense, H. Schunkert beteiligte Studiengruppe KNHI (Lübeck, Regensburg, Neuherberg, Münster) | |
(V954) | Effects of beta-blocker therapy on hs-CRP and NTproBNP in elderly patients with ischaemic and non-ischaemic heart failure: Results from CIBIS-ELD |
E. Isenovic, B. Putnikovic, P. Milicevic, T. D. Trippel, D. Obradovic, V. Tscholl, S. von Haehling, F. Edelmann, R. Wachter, W. Haverkamp, H.-D. Düngen on behalf of KNHI (Belgrade, CS; Berlin, Göttingen) | |
(V955) | RAnoLazIne for the treatment of Diastolic Heart Failure in patients with preserved ejection fraction: Results from the RALI-DHF study |
L. S. Maier, R. Wachter, B. Layug, E. Karwatowska-Prokopczuk, L. Berladinelli, G. Hasenfuß, C. Jacobshagen (Göttingen; Foster City / Palo Alto, US) | |
(V956) | Keynote Lecture: State of the Art |
C. E. Angermann (Würzburg) |